Latest ACOR reports update at 2024-05-14: 2024-Q1 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Acorda Therapeutics
  4. Financial Ratios
Acorda Therapeutics logo
Acorda Therapeutics ACOR
$ 0.66 -24.86%
mail-toReport an Error

Acorda Therapeutics Financial Ratios 2011-2024 | ACOR

Annual Financial Ratios Acorda Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -0.1 -0.2 -0.1 -0.5 -0.4 23.0 -5.4 -25.6 140.6 96.8 73.3 7.3 32.6

P/S

 0.1 0.1 0.1 0.4 0.5 1.6 2.1 1.7 3.2 4.3 3.6 3.7 3.4

EPS

 -203.6 -65.2 -9.8 -12.3 -34.4 0.7 -4.9 -0.8 0.3 0.4 0.4 3.9 0.8

EV (Enterprise Value)

 -13.2 M -23.9 M -35 M 378 M 528 M 1.17 B 1.59 B 1.41 B 1.92 B 2.07 B 1.32 B 1.27 B 1.11 B

EBITDA per Share

 -188 -2.5 -4.24 -6.94 -12 13.4 16.7 -0.769 8.51 7.88 5.58 4.6 6.1

EV/EBITDA

 0.8 -4.0 -2.7 8.0 9.8 -185.4 28.6 33.8 31.3 36.6 23.9

PEG

 -0.0 0.0 0.0 -0.01 0.0 0.2 0.01 0.07 -3.56 19.83 -0.82 0.02 0.09

P/B

 0.2 0.0 0.0 0.2 0.3 1.3 2.3 1.3 2.6 3.2 2.7 2.9 4.9

P/CF

 -1.2 -0.7 -0.3 -0.8 -0.5 6.6 14.8 -3.7 49.5 -4.2 49.0 29.5 16.5

ROE %

 160.08 -70.41 -68.78 -41.85 -87.82 5.50 -42.95 -5.21 1.83 3.27 3.73 40.15 14.91

ROA %

 -232.99 -16.66 -22.82 -15.74 -34.13 2.59 -18.64 -2.58 0.99 1.64 2.71 27.41 8.06

ROCE %

 167.74 -37.75 -52.30 -17.54 -16.96 8.06 9.95 -2.29 4.38 4.72 5.95 5.49 12.00

Current Ratio

 - - - 1.6 2.3 3.8 3.1 1.8 5.0 3.6 3.8 3.4 4.1

DSO

 48.3 47.5 52.6 48.2 41.9 18.1 50.5 36.7 23.3 29.3 33.4 31.4 28.5

DIO

 345.2 188.3 211.3 312.3 264.2 106.6 100.9 145.6 143.3 121.5 143.3 132.7 155.6

DPO

 276.8 124.3 102.9 140.3 281.1 181.4 83.6 101.0 67.0 91.9 98.5 153.1 117.3

Operating Cycle

 393.5 235.8 263.9 360.5 306.1 124.8 151.4 182.3 166.6 150.8 176.7 164.1 184.1

Cash Conversion Cycle

 116.7 111.6 161.0 220.2 25.0 -56.7 67.8 81.3 99.5 58.9 78.2 11.0 66.8

All numbers in USD currency

Quarterly Financial Ratios Acorda Therapeutics

2024-Q1 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -22.06 -13.54 - -0.57 -2.78 -1.85 - -2.43 -2.29 -3.53 - 0.92 -2.19 -0.81 1.38 -5.55 -0.58 -1 0.2 -0.29 0.99 -0.18 -3.7 -0.55 -0.18 -0.41 -0.07 -0.28 -0.4 -0.01 0.22 0.09 0.02 -0.07 0.01 0.29 0.11 0.02 0.15 0.19 0.1 -0.03 3.36 0.24 0.12 0.2 0.32 0.48 -0.01 -0.02

EBITDA per Share

 -15.1 -2.87 - 0.81 0.18 -0.62 - 0.22 0.15 -2.14 - 5.9 1.4 0.49 - -4.94 -0.18 -0.81 - 0.79 1.4 0.08 - 0.33 0.31 -0.21 - 0.23 -0.09 -0.3 - 0.87 0.31 0.06 - 0.64 0.36 0.13 - 0.4 0.29 -0.03 - 0.34 0.18 0.25 - 0.61 0.08 0.04

ROE %

 -43.68 -111.54 -90.61 -107.07 -105.25 -64.15 -44.68 -41.59 -22.04 -17.36 -6.95 14.17 -73.70 -75.23 -87.82 -107.38 -24.86 -8.47 5.35 -29.11 -31.69 -40.81 -42.95 -10.52 -7.63 -8.88 -5.32 -3.33 -0.69 2.30 1.87 0.40 1.93 2.63 3.27 4.62 4.10 4.12 3.73 36.78 37.57 37.86 40.15 11.88 18.59 17.27 14.91 9.19 -0.14 -0.33

ROA %

 -45.11 -23.02 -20.79 -26.60 -28.89 -22.05 -16.19 -15.03 -8.06 -6.16 -2.62 5.60 -28.52 -29.20 -34.13 -41.60 -9.72 -2.73 2.59 -12.43 -13.46 -17.70 -18.64 -4.60 -3.46 -4.19 -2.65 -1.59 -0.27 1.23 1.00 0.20 0.95 1.29 1.64 2.62 2.75 2.96 2.71 25.21 25.67 25.83 27.41 7.23 10.51 9.63 8.06 4.97 -0.08 -0.18

ROCE %

 -17.52 -43.91 -35.51 -49.50 -56.90 -49.31 -36.18 -29.44 -8.71 -4.49 0.13 -83.31 -173.49 -177.00 -104.92 -100.30 -12.23 4.94 14.35 13.94 8.90 -0.23 -2.83 -3.65 -4.06 -6.67 -5.42 -0.96 4.33 7.37 5.20 9.06 8.45 9.53 6.52 9.10 7.83 7.78 4.00 6.69 6.79 6.12 6.29 16.36 23.75 22.88 10.73 10.07 0.45 0.21

Current Ratio

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

 41.3 47.3 - 39.4 38.6 58.7 - 40.0 44.9 59.3 - 34.7 54.8 68.6 39.9 42.2 40.3 47.0 30.9 15.0 13.9 45.0 39.4 52.7 53.3 51.1 - 35.1 37.4 33.0 - 19.4 25.2 29.1 - 27.7 30.3 35.7 - 33.1 32.3 36.3 - 31.0 31.8 31.5 - 22.4 31.9 -

DIO

 339.5 369.9 - 126.8 156.3 255.3 - 157.6 212.6 214.0 - 215.0 393.0 639.9 - 288.2 244.9 281.2 - 105.3 87.2 147.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 157.4 178.7 - 80.7 86.7 150.0 - 113.1 108.7 82.6 - 91.1 166.6 456.0 - 300.0 255.0 389.5 - 177.3 146.8 168.6 - 83.3 84.2 - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 380.8 417.1 - 166.2 194.9 314.0 - 197.6 257.6 273.2 - 249.7 447.8 708.5 39.9 330.4 285.2 328.3 30.9 120.2 101.1 192.1 39.4 52.7 53.3 51.1 - 35.1 37.4 33.0 - 19.4 25.2 29.1 - 27.7 30.3 35.7 - 33.1 32.3 36.3 - 31.0 31.8 31.5 - 22.4 31.9 -

Cash Conversion Cycle

 223.5 238.5 - 85.5 108.2 164.0 - 84.5 148.9 190.7 - 158.6 281.2 252.5 39.9 30.4 30.2 -61.2 30.9 -57.0 -45.7 23.6 39.4 -30.6 -30.9 51.1 - 35.1 37.4 33.0 - 19.4 25.2 29.1 - 27.7 30.3 35.7 - 33.1 32.3 36.3 - 31.0 31.8 31.5 - 22.4 31.9 -

All numbers in USD currency